Cerus reported $-20.92M in Net Income for its fiscal quarter ending in December of 2024.





Net Income Change Date
Cerus USD -20.92M 17.98M Dec/2024
GRIFOLS EUR 73M 25.25M Mar/2026
Haemonetics USD 44.74M 6.06M Dec/2025
Neogen USD -17M 1.08M Dec/2025
OraSure Technologies USD -19.29M 5.57M Dec/2025
Plus Therapeutics USD -5.71M 1.29M Dec/2025
Quidel USD -91.8M 38.9M Mar/2026
Rockwell Medical USD 343K 2.07M Jun/2024
STAAR Surgical USD 5.21M 23.52M Mar/2026
Terumo JPY 26.37B 6.28B Mar/2026
Utah Medical Products USD 2.57M 445K Dec/2025